13641611000001109: Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Atazanavir\Product containing only atazanavir in oral dose form (medicinal product form)\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Atazanavir\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Trade family\Reyataz\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing atazanavir\Atazanavir\Product containing only atazanavir in oral dose form (medicinal product form)\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing atazanavir\Atazanavir\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing atazanavir\Product containing atazanavir in oral dose form (medicinal product form)\Product containing only atazanavir in oral dose form (medicinal product form)\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing atazanavir\Atazanavir\Product containing only atazanavir in oral dose form (medicinal product form)\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing atazanavir\Atazanavir\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing atazanavir\Product containing atazanavir in oral dose form (medicinal product form)\Product containing only atazanavir in oral dose form (medicinal product form)\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing atazanavir\Atazanavir\Product containing only atazanavir in oral dose form (medicinal product form)\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing atazanavir\Atazanavir\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing atazanavir\Product containing atazanavir in oral dose form (medicinal product form)\Product containing only atazanavir in oral dose form (medicinal product form)\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing atazanavir in oral dose form (medicinal product form)\Product containing only atazanavir in oral dose form (medicinal product form)\Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule\Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

48648801000001116 Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

48648901000001110 Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only	true	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule	true	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has active ingredient	Atazanavir	false	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral capsule	true	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Reyataz	true	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Atazanavir	true	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has specific active ingredient	Atazanavir sulfate	true	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has active ingredient	Atazanavir sulfate	false	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has dispensed dose form	Capsule	true	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has basis of strength substance	Atazanavir	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 capsule	Is pack of	False	Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 capsule	Has AMP	True	Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
48648801000001116	Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
48648901000001110	Reyataz 300mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module